Ignite Creation Date:
2024-05-06 @ 3:04 PM
Last Modification Date:
2024-10-26 @ 1:42 PM
Study NCT ID:
NCT04518319
Status:
SUSPENDED
Last Update Posted:
2023-04-18
First Post:
2020-08-13
Brief Title:
Clinical Intervention on Cognitive Impairment of Schizophrenia With Metabolic Syndrome
Sponsor:
Shanghai Mental Health Center
Organization:
Shanghai Mental Health Center
Study Overview
Official Title:
Clinical Comprehensive Intervention on Cognitive Impairment of Schizophrenia Patients With Metabolic Syndrome
Status:
SUSPENDED
Status Verified Date:
2023-04
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
The COVID-19 affects the recruitment of patients
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
This is a single-center randomized parallel-control study conducted in schizophrenic inpatients with metabolic syndrome who have been conducted with olanzapine The purpose of this study is to evaluate the efficacy and safety of omega-3 polyunsaturated fatty acids Xbox aerobic exercise and transcranial direct current stimulation tDCS Following a screening period subjects who meet the entry criteria will be randomized to treated with omega-3 polyunsaturated fatty acids12mg per day Xbox aerobic exercise 30min per day and tDCS at 2mA 20 min5 sessionweek for 12 weeks
Detailed Description:
None
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
False
Is a FDA Regulated Device?:
False
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None